COL1A1 polymorphism and neurological complications in pediatric acute lymphoblastic leukemia patients and their associations with altered bone mineral density

Faculty Medicine Year: 2020
Type of Publication: ZU Hosted Pages:
Authors:
Journal: Egyptian Journal of Medical Human Genetics Springer Volume:
Keywords : COL1A1 polymorphism , neurological complications , pediatric acute    
Abstract:
Background: Osteoporosis and neurological complications are consequences of acute lymphoblastic leukemia (ALL). Collagen type I alpha 1 gene (COL1A1) polymorphism is associated with osteoporosis. This study aimed to detect the COL1A1 polymorphism and the neurological complications in ALL patients and their association with decreased lumbar spine bone mineral density (BMDLS). This study included 100 pediatric ALL patients and 100 controls. All participants were subjected to laboratory assessment and assessment of BMDLS at the start of the study and 3 years later. COLIA1 genotyping was done once for all participants. Results: At the start of the study, there was a significant decrease in osteocalcin (OC), alkaline phosphatase (ALP), and BMDLS levels in the patients. G/T variants and “T” alleles were significantly more detected in the patients (34% and 35% respectively); also, significant differences were detected between patients with polymorphism (G/T and T/ T) and those without polymorphism (G/G) regarding OC, ALP, and BMDLS. After 3 years, significant decrement in BMDLS, OC, and ALP was detected in the patients. Twenty-four patients had neurological complications and seven patients had bone fractures. Those patients had significant decrement in BMDLS, OC, and ALP levels. As regards COL1A1 gene polymorphism, the GT and TT variants were significantly detected in fractured patients, while there was no significant difference regarding GT and TT variants in the patients with neurological complications. T allele, neurological complications, high-risk stratification, and age were significantly associated with decreased BMDLS. T allele was the most significant risk factor. Conclusion: COLIA1 gene polymorphism, decreased BMDLS, and neurological complications were significantly detected in pediatric ALL patients. COLIA1 gene polymorphism is a significant risk factor for decreased BMDLS in pediatric ALL patients. There is no significant relation between COLIA1 gene polymorphism and the development of neurologic complications.
   
     
 
       

Author Related Publications

  • Alaa Abdelmoaty Ahmed Omran, "Anti-C1q and anti-dsDNA antibodies in systemic lupus erythematosus: Relationship with disease activity and renal involvement in Sharkia governorate- Egypt", Elsevier, 2011 More
  • Alaa Abdelmoaty Ahmed Omran, "Expression and diagnostic utility of single and combined CD200, CD148 and CD160 markers in mature B‑cell neoplasms as revealed by ROC and SVM analyses", World academy of sciences journal, 2019 More
  • Alaa Abdelmoaty Ahmed Omran, "Serum level of midregional fragment of proadrenomedullin as an early sepsis marker in severely neutropenic patients with hematologic malignancies", The Egyptian Journal of Haematology, 2019 More
  • Alaa Abdelmoaty Ahmed Omran, "The Predictive Value of Vanin-1 in Pediatric Immune Thrombocytopenia", https://ejhm.journals.ekb.eg/, 2021 More

Department Related Publications

  • Mage Munir Hussein Fawzi, "Association of ficolin-2 gene polymorphisms and susceptibility to systemic lupus erythematosus in Egyptian children and adolescents: a multicenter study", SAGE Journals, 2019 More
  • Mona Elsayed Hashim Muhammad, "Common MEFV Mutations Analysis in Egyptian Patients with Familial Mediterranean Fever", ELSEVEIR, 2010 More
  • Mona Elsayed Hashim Muhammad, "Serum Soluble transferrin receptors concentration as an accurate estimate of body iron store over serum ferritin in patients of type 2 diabetes", جامعة الازهر, 2010 More
  • Amal Ahmed Ali Zedan, "Vitamin D Receptor Gene Polymorphism as a Prognostic Marker in Acute Myeloid Leukemia Patients", www.ijpras.com, 2018 More
  • Ahmed Mahmoud Ahmed Hasanien, "Impact of Helicobacter Pylori eradication on refractory thrombocytopenia in patients with chronic HCV awaiting antiviral therapy.", SPRINGER, 2016 More
Tweet